HealthEquity (NASDAQ:HQY) Share Price Passes Above 50 Day Moving Average – Should You Sell?

Shares of HealthEquity, Inc. (NASDAQ:HQY) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $85.20 and traded as high as $85.63. HealthEquity shares last traded at $83.43, with a volume of 715,138 shares.

Analyst Ratings Changes

A number of research firms recently issued reports on HQY. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. JPMorgan Chase & Co. lowered their price objective on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Finally, Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $110.57.

HealthEquity Stock Performance

The firm has a fifty day moving average of $85.30 and a 200-day moving average of $84.77. The firm has a market cap of $7.40 billion, a P/E ratio of 33.13, a PEG ratio of 1.40 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. This represents a 11.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,081 shares of company stock valued at $1,193,000 over the last ninety days. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently modified their holdings of the stock. Acumen Wealth Advisors LLC acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd boosted its position in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd bought a new position in shares of HealthEquity during the fourth quarter worth $28,000. Leonteq Securities AG grew its holdings in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after buying an additional 235 shares during the period. Finally, Axiom Investment Management LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at $33,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.